Back to results
US 10,369,159 B2Granted
Estrogen receptor β partial agonist having estrogen receptor α inhibitory effect, and gynecological disease therapeutic agent using same
AssigneesNobelpharma AB, National University Corporation Tottori University
InventorsKenichiro Nakao, Tasuku Harada, Fuminori Taniguchi
Life of this patent
Estimating the term…
Abstract
[Problem] To provide a therapeutic agent for estrogen-dependent gynecological diseases such as endometriosis, uterine fibroids, and uterus adenomyosis. [Solution] To use an estrogen receptor α-inhibiting β partial agonist represented by the formula (a), a pharmaceutically-acceptable salt thereof, or a hydrate of either of the afore-mentioned, as an active ingredient.
Claims4
A method of treating a gynecological disease, comprising:
- administering an effective amount of a compound represented by following formula (a);
- to a patient in need thereof,
- wherein the gynecological disease is at least one disease selected from the group consisting of endometriosis, uterine fibroids, and uterus adenomyosis.
Dependencies are inferred from the claim text.